Your browser doesn't support javascript.
loading
Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China.
Zong, Zhaojing; Jing, Wei; Shi, Jin; Wen, Shu'an; Zhang, Tingting; Huo, Fengmin; Shang, Yuanyuan; Liang, Qian; Huang, Hairong; Pang, Yu.
Affiliation
  • Zong Z; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
  • Jing W; Department of Respiratory Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou Province, China.
  • Shi J; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
  • Wen S; Beijing Pediatric Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.
  • Zhang T; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
  • Huo F; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
  • Shang Y; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
  • Liang Q; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
  • Huang H; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
  • Pang Y; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China huanghairong@tb123.org pangyupound@163.com.
Antimicrob Agents Chemother ; 62(8)2018 08.
Article de En | MEDLINE | ID: mdl-29844043
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Régulation de l'expression des gènes bactériens / Oxazolidinones / Multirésistance bactérienne aux médicaments / Linézolide / Gènes bactériens / Mycobacterium tuberculosis / Antituberculeux Type d'étude: Observational_studies Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: Antimicrob Agents Chemother Année: 2018 Type de document: Article Pays d'affiliation: Chine
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Régulation de l'expression des gènes bactériens / Oxazolidinones / Multirésistance bactérienne aux médicaments / Linézolide / Gènes bactériens / Mycobacterium tuberculosis / Antituberculeux Type d'étude: Observational_studies Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: Antimicrob Agents Chemother Année: 2018 Type de document: Article Pays d'affiliation: Chine